Tumor clone frequency is a robust predictor of progression and survival in patients with Stage IB mycosis fungoides. (September 2018) - De Masson, Adele; O'Malley, John T.; Lowry, Elizabeth L.; Leboeuf, Nicole R.; Elco, Christopher P.; Garcia, Sarah; Teague, Jessica E.; Robins, Harlan; Divito, Sherrie; Clark, Rachael A.; Kupper, Thomas S.